provider image
Welcome! You’re in GoodRx for healthcare professionals. Now, you’ll enjoy a streamlined experience created specifically for healthcare professionals.
Skip to main content
HomeDrugsJardiance

Fast Facts on Jardiance: Uses, Side Effects, Dosage, Costs, and More

Jenna Clayton, PharmDKristine Foley, PharmD
Updated on December 2, 2024

Key takeaways:

  • Type 2 diabetes, heart disease, and chronic kidney disease affect many U.S. adults. Jardiance (empagliflozin) is a prescription medication that can help manage these conditions. It may potentially cause weight loss, too.

  • Jardiance is a once-daily tablet taken by mouth. It’s often taken in the morning with or without food.

  • There are ways to save on Jardiance. If you’re eligible, a manufacturer savings card can help you access Jardiance for as little as $10 per month. A patient assistance program is also available.

A HCP explaining a pill bottle to a patient.
brizmaker/iStock via Getty Images Plus

There are three types of diabetes, but more than 90% of people living with diabetes have Type 2 diabetes. Due to its common but potentially serious nature, many pharmaceutical companies are developing new medications to treat it.

One growing category of medications used to treat Type 2 diabetes is sodium-glucose cotransporter-2 (SGLT2) inhibitors. This group of medications includes Jardiance (empagliflozin), Farxiga (dapagliflozin), Invokana (canagliflozin), and more.

Several SGLT2 inhibitors — especially Jardiance and Farxiga — are becoming quite popular. In fact, SGLT2 inhibitors have been incorporated into clinical guidelines as a recommended treatment option for Type 2 diabetes and other related conditions (which we’ll discuss later).

Promotion disclosure
Avg retail price
$847.74(Save 26.91%)
GoodRx discount
$619.65
How it works
drug-savings-illustration-1Use GoodRx to find medications, pharmacies, and discounts.
drug-savings-illustration-2GoodRx discounts can help you pay less for your prescription.
drug-savings-illustration-3Bring your free coupon or savings card to the pharmacy.

You can find Jardiance as a brand-name tablet. You can also find its active ingredient in a combination tablet with metformin (branded as Synjardy). Here, we’ll dive deeper into Jardiance’s uses, side effects, cost, and more.

What is Jardiance, and how does it work?

Jardiance is a once-daily tablet that’s FDA approved to treat Type 2 diabetes — in addition to a diabetes-friendly diet and routine exercise — in adults and children age 10 years and older.

Jardiance belongs to a drug class called SGLT2 inhibitors. It works in your kidneys to reduce the amount of glucose (sugar) that’s reabsorbed into your bloodstream. This excess glucose is then released into your urine so it can leave your body. Jardiance also reduces the amount of salt that your body reabsorbs.

What else is Jardiance used for?

Jardiance was initially approved for Type 2 diabetes in 2014. It’s been approved for additional conditions since then. Jardiance can:

  • Lower the risk of cardiovascular death in adults who have Type 2 diabetes and heart disease

  • Lower the risk of cardiovascular death and hospitalization in adults with heart failure

  • Lower the risk of cardiovascular death, hospitalization, and kidney disease progression in adults with chronic kidney disease

With these additional approvals, it now can be widely used for these four different purposes.

Good to know: Jardiance is not meant to be used by people with Type 1 diabetes or severe kidney problems.

Does Jardiance cause weight loss?

Jardiance may potentially help with weight loss. This is an off-label use. In one study, people lost an average 4 lbs to 6 lbs after taking Jardiance for about 6 months. Other data shows similar weight-loss results.

GoodRx icon
  • What’s it like to take Jardiance? Three people share their Jardiance stories.

  • Does Jardiance have a generic? Not yet, but there are still ways to save. Here are some pharmacist-backed tips to save on Jardiance.

  • Any serious side effects? Diabetic ketoacidosis (DKA) is a potentially serious side effect of Jardiance. Learn how to identify DKA symptoms and respond to them.

It’s important to note that potential weight-loss benefits vary. Whether and how much weight you lose is impacted by factors such as diet, exercise, and other medications you may be taking, like metformin.

Are there any other benefits?

Yes. Aside from its effects on body weight, Jardiance has other potential benefits. These include:

  • Lower systolic blood pressure: Although Jardiance isn’t prescribed to treat high blood pressure directly, it may modestly lower systolic blood pressure (the top number in your blood pressure reading).

  • Heart benefits: People with Type 2 diabetes are more likely to experience heart issues. In clinical studies, Jardiance was found to help protect the heart, which researchers refer to as “cardioprotective effects.” These protective benefits are on top of those already gained through improving blood glucose levels. These findings led to Jardiance’s heart-related FDA approvals.

  • Kidney benefits: Jardiance helps protect the kidneys. In fact, in a study of people with Type 2 diabetes who also had heart disease, Jardiance lowered the risk of new or worsening kidney disease by 39% compared to placebo. This is relevant because people with Type 2 diabetes have a higher risk of eventually developing kidney disease. This data contributed to Jardiance’s approval in chronic kidney disease.

What are the possible side effects of Jardiance?

Not too many people experience bothersome side effects from Jardiance, but a few risks have been reported.

Possible Jardiance side effects include:

  • Frequent urination

  • Urinary tract infections

  • Genital yeast infections

  • Upper respiratory tract infections

  • Joint pain

Less common but potentially serious side effects of Jardiance are hypoglycemia (low blood glucose), dehydration, and ketoacidosis (excess acid in the blood). But one positive note is that unlike Invokana, another SGLT2 inhibitor with heart benefits, Jardiance hasn’t been found to raise the risk of bone fractures.

Does Jardiance interact with any other medications?

Yes, Jardiance can interact with other medications. There are two main groups of medications that Jardiance tends to interact with: other blood glucose-lowering medications and diuretics.

Blood glucose-lowering medications

When Jardiance is used alongside other medications that lower glucose levels, it’s possible that your blood glucose could drop too low.

This risk of hypoglycemia appears to be highest when Jardiance is used with sulfonylureas, glinides, or insulin. Examples of sulfonylurea medications include glipizide, glimepiride (Amaryl), and glyburide (Glynase, DiaBeta). Repaglinide is one glinide that can interact with Jardiance. And several types of insulin can cause interactions, such as Lantus (insulin glargine), Humalog (insulin lispro), and Novolog (insulin aspart), to name a few.

Diuretics 

Diuretic medications help your body get rid of excess fluid. They’re sometimes referred to as “water pills.” Furosemide (Lasix) is a common example.

When you take Jardiance at the same time as a diuretic, there’s a higher risk of experiencing dehydration. This is because both medications work by making you get rid of more fluid than normal. This combination can make you go to the bathroom more frequently.

What are the recommended Jardiance dosages?

Jardiance is a tablet that you take by mouth once daily. It comes in two different tablet sizes: 10 mg and 25 mg. You can take it in the morning with or without food.

As mentioned earlier, Jardiance contains the active ingredient empagliflozin. Many people take it in combination with metformin. While you can take them separately, a combination medication is available, too. Synjardy is a medication that contains both empagliflozin and metformin in the same tablet. Synjardy is available in many doses, and it’s usually taken once or twice daily.

What do I need to know about Jardiance 10 mg?

When you first start taking Jardiance, you’ll likely start off by taking Jardiance 10 mg by mouth every morning. But, if your blood glucose levels remain high, a healthcare professional may increase your dose. They might raise your daily dose to 25 mg.

Alternatively, they might consider adjusting the doses of your other diabetes medications to help further reduce your blood glucose levels.

Farxiga vs. Jardiance

Farxiga and Jardiance are SGLT2 inhibitors that are relatively similar overall. They’re both oral tablets taken once daily and are recommended treatment options according to the American Diabetes Association. One key difference between the two is that Farxiga has a generic version available.

A healthcare professional may prescribe you one of these medications depending on your situation, medical history, and insurance coverage status.

How to save on Jardiance

Without insurance, a 30-day supply of Jardiance may cost $764.16 on average. But there are ways to save on Jardiance, which is only available as a brand-name medication.

GoodRx can help you navigate between copay savings cards and patient assistance programs to save money on your prescription.

  • Save with a copay savings card. If you have commercial insurance, you may be eligible to pay as little as $10 for Jardiance using a savings card from the manufacturer.

  • Save with patient assistance programs. If you’re uninsured or underinsured, you may be eligible for Jardiance’s patient assistance program, which offers the medication free of cost.

The bottom line

Jardiance (empagliflozin) is an oral, prescription-only medication that’s FDA approved to treat Type 2 diabetes. It can also reduce the risk of complications related to heart disease, heart failure, and kidney disease. It may offer off-label benefits too, such as weight loss, but this depends on the person. 

If you have any questions or concerns about Jardiance, talk to a pharmacist or other healthcare professional. They can help you determine whether this medication is right for you.

why trust our exports reliability shield

Why trust our experts?

Jenna Clayton, PharmD
Jenna Clayton, PharmD earned her Doctor of Pharmacy degree at the University at Buffalo School of Pharmacy and Pharmaceutical Sciences in Buffalo, New York. Throughout her doctoral program, Jenna gained experience in a variety of pharmaceutical settings, including community, hospital, long-term care, and ambulatory care settings.
Joshua Murdock, PharmD, BCBBS
Joshua Murdock, PharmD, BCBBS, is a licensed pharmacist in Arizona, Colorado, and Rhode Island. He has worked in the pharmacy industry for more than 10 years and currently serves as a pharmacy editor for GoodRx.
Kristine Foley, PharmD
Kristine Foley is a licensed pharmacist with over 13 years of community pharmacy experience. She earned her Doctor of Pharmacy degree from Rutgers University.

References

American Diabetes Association. (2024). Pharmacologic approaches to glycemic treatment: standards of care in diabetes- 2024. Diabetes Care.

Boehringer Ingelheim Pharmaceuticals, Inc. (2014). FDA approves Jardiance (empagliflozin) tablets for adults with type 2 diabetes.

View All References (11)

Boehringer Ingelheim Pharmaceuticals, Inc. (2024). Jardiance- empagliflozin tablet, film coated [package insert]. DailyMed.

Centers for Disease Control and Prevention. (2024). Diabetes basics.

Kohler, S., et al. (2018). Analysis of fractures in patients with type 2 diabetes treated with empagliflozin in pooled data from placebo-controlled trials and a head-to-head study versus glimepiride. Diabetes Care.

Klein, H. E. (2023). FDA grants approval for empagliflozin in chronic kidney disease. American Journal of Managed Care.

Melillo, G. (2022). FDA approves empagliflozin for broader type of heart failure. American Journal of Managed Care.

National Institute of Diabetes and Digestive and Kidney Diseases. (2017). Diabetic kidney disease.

Neeland, I. J., et al. (2016). Empagliflozin reduces body weight and indices of adipose distribution in patients with type 2 diabetes mellitus. National Library of Medicine.

Ribola, F. A., et al. (2017). Effects of SGLT2 inhibitors on weight loss in patients with type 2 diabetes mellitus. European Review for Medical and Pharmacological Sciences.

U.S. Food and Drug Administration. (2016). FDA approves Jardiance to reduce cardiovascular death in adults with type 2 diabetes.

Wanner, C. et al. (2016). Empagliflozin and progression of kidney disease in type 2 diabetes. New England Journal of Medicine.

Zinman, B., et al. (2015). Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes. New England Journal of Medicine.

GoodRx Health has strict sourcing policies and relies on primary sources such as medical organizations, governmental agencies, academic institutions, and peer-reviewed scientific journals. Learn more about how we ensure our content is accurate, thorough, and unbiased by reading our editorial guidelines.

Was this page helpful?

Learn How to Lower Your A1C

Join our 12-week newsletter series that has the lifestyle, diet, and medication information you need to help lower your A1C.

By signing up, I agree to GoodRx's Terms and Privacy Policy, and to receive marketing messages from GoodRx.

Related Articles

Browse medications

View All

Research prescriptions and over-the-counter medications from A to Z, compare drug prices, and start saving.